
MDL 72527
CAS No. 93565-01-6
MDL 72527( N1,N4-Di(buta-2,3-dien-1-yl)butane-1,4-diamine dihydrochloride )
Catalog No. M24989 CAS No. 93565-01-6
MDL 72527 is a polyamine oxidase (POA) inhibitor
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 43 | In Stock |
![]() ![]() |
5MG | 72 | In Stock |
![]() ![]() |
10MG | 115 | In Stock |
![]() ![]() |
25MG | 237 | In Stock |
![]() ![]() |
50MG | 385 | In Stock |
![]() ![]() |
100MG | 575 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameMDL 72527
-
NoteResearch use only, not for human use.
-
Brief DescriptionMDL 72527 is a polyamine oxidase (POA) inhibitor
-
DescriptionMDL 72527 is a polyamine oxidase (POA) inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsN1,N4-Di(buta-2,3-dien-1-yl)butane-1,4-diamine dihydrochloride
-
PathwayOthers
-
TargetOther Targets
-
Recptorpolyamine oxidase (POA)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number93565-01-6
-
Formula Weight265.22
-
Molecular FormulaC12H22Cl2N2
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESC=C=CCNCCCCNCC=C=C.Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Guoxing, Liu, Hang, et al. Effect of Lysosomotropic Polyamineoxidase Inhibitor MDL-72527 on Platelet Activation.[J]. Cellular Physiology & Biochemistry International Journal of Experimental Cellular Physiology Biochemistry & Pharmacology, 2016.
molnova catalog



related products
-
4A3-SC8
4A3-SC8 is a modular dendritic macromolecule with cationic and lipophilic groups that enables small RNAs to prolong survival in an aggressive hepatocellular carcinoma model and can be used to synthesize lipid nanoparticles.
-
Cadazolid
Cadazolid is an oxazolidinone-type antibiotic, with activity against gram-positive bacteria, including Clostridium difficile.
-
SARS-CoV-2 3CLpro-IN...
SARS-CoV-2 3CLpro-IN-16 is a covalent inhibitor of SARS-CoV-2 3CLpro activity, exerting its effect by forming a covalent bond with Cys145.